Home Search Contact Us Site Map Lombardi Comprehensive Cancer Center Privacy Notice Legal Statements
spacer spacer spacer
Clinical CareResearchEducationAbout LombardiHow to Help
spacer spacer clear clear
photo spacer

Program Overview

spacer

Program Leader

spacer

Program Members

spacer

Scientific Accomplishments

spacer

Selected Publications

spacer 		spacer

Home » Research

Growth Regulation of Cancer Program

SELECTED PUBLICATIONS

2006 Earlier Publications

2006

  • Lecanu L, Greeson J, Papadopoulos V. Beta-amyloid and oxidative stress jointly induce neuronal death, amyloid deposits, gliosis, and memory impairment in the rat brain. Pharmacology 2006; 76:19-33.

  • Xie B, Tassi E, Swift MR, McDonnell K, Bowden ET, Wang S, Ueda Y, Tomita Y, Riegel AT, Wellstein A. Identification of the fibroblast growth factor (FGF)-interacting domain in a secreted FGF-binding protein by phage display. J Biol Chem 2006; 281:1137-1144.

  • Briones VR, Chen S, Riegel AT, Lechleider RJ. Mechanism of fibroblast growth factor-binding protein 1 repression by TGF-beta. Biochem.Biophys.Res.Commun. 2006; 345:595-601.

  • Casey JL, Gerin JL. The woodchuck model of HDV infection. Curr.Top.Microbiol.Immunol. 2006; 307:211-225.

  • Casey JL. RNA editing in hepatitis delta virus. Curr.Top.Microbiol.Immunol. 2006; 307:67-89.

  • Casey JL, Tennant BC, Gerin JL. Genetic changes in hepatitis delta virus from acutely and chronically infected woodchucks. J.Virol. 2006; 80:6469-6477.

  • Fricke ST, Rodriguez O, Vanmeter J, Dettin LE, Casimiro M, Chien CD, Newell T, Johnson K, Ileva L, Ojeifo J, Johnson MD, Albanese C. In vivo magnetic resonance volumetric and spectroscopic analysis of mouse prostate cancer models. Prostate 2006; 66:708-717.

  • Fu M, Liu M, Sauve AA, Jiao X, Zhang X, Powell M, Yang T, Gu W, Avantaggiati ML, Pattabiraman N, Pestell TG, Wang F, Quong A, Wang C, Pestell RG. The Hormonal Control of Androgen Receptor Function through SIRT1. Mol.Cell Biol. 2006.

  • He Z, Chan WY, Dym M. Microarray technology offers a novel tool for the diagnosis and identification of therapeutic targets for male infertility. Reproduction. 2006; 132:11-19.

  • Jagadeesh S, Banerjee PP. Inositol hexaphosphate represses telomerase activity and translocates TERT from the nucleus in mouse and human prostate cancer cells via the deactivation of Akt and PKCalpha. Biochem.Biophys.Res.Commun. 2006; 349:1361-1367.

  • Jagadeesh S, Banerjee PP. Telomerase reverse transcriptase regulates the expression of a key cell cycle regulator, cyclin D1. Biochem.Biophys.Res.Commun. 2006; 347:774-780.

  • Jagadeesh S, Kyo S, Banerjee PP. Genistein represses telomerase activity via both transcriptional and posttranslational mechanisms in human prostate cancer cells. Cancer Res. 2006; 66:2107-2115.

  • Ju JH, Maeng JS, Zemedkun M, Ahronovitz N, Mack JW, Ferretti JA, Gelmann EP, Gruschus JM. Physical and functional interactions between the prostate suppressor homeoprotein NKX3.1 and serum response factor. J.Mol.Biol. 2006; 360:989-999.

  • Kang HJ, Kim HJ, Kim SK, Barouki R, Cho CH, Khanna KK, Rosen EM, Bae I. BRCA1 modulates xenobiotic stress-inducible gene expression by interacting with ARNT in human breast cancer cells. J.Biol.Chem. 2006; 281:14654-14662.

  • Kang HJ, Kim HJ, Rih JK, Mattson TL, Kim KW, Cho CH, Isaacs JS, Bae I. BRCA1 plays a role in the hypoxic response by regulating HIF-1alpha stability and by modulating vascular endothelial growth factor expression. J.Biol.Chem. 2006; 281:13047-13056.

  • Khwaja F, Tabassum A, Allen J, Djakiew D. The p75(NTR) tumor suppressor induces cell cycle arrest facilitating caspase mediated apoptosis in prostate tumor cells. Biochem.Biophys.Res.Commun. 2006; 341:1184-1192.

  • Knights CD, Catania J, Di GS, Muratoglu S, Perez R, Swartzbeck A, Quong AA, Zhang X, Beerman T, Pestell RG, Avantaggiati ML. Distinct p53 acetylation cassettes differentially influence gene-expression patterns and cell fate. J.Cell Biol. 2006; 173:533-544.

  • Korba BE, Furman PA, Otto MJ. Clevudine: a potent inhibitor of hepatitis B virus in vitro and in vivo. Expert.Rev.Anti.Infect.Ther. 2006; 4:549-561.

  • Krom BP, Cohen JB, Elhaney Feser GE, Cihlar RL. Optimized candidal biofilm microtiter assay. J.Microbiol.Methods 2006.

  • Kumar PA, Pitteloud N, Andrews PA, Dwyer A, Hayes F, Crowley WF, Jr., Dym M. Testis morphology in patients with idiopathic hypogonadotropic hypogonadism. Hum.Reprod. 2006; 21:1033-1040.

  • Kuo AH, Stoica GE, Riegel AT, Wellstein A. Recruitment of insulin receptor substrate-1 and activation of NF-kappaB essential for midkine growth signaling through anaplastic lymphoma kinase. Oncogene 2006.

  • Lecanu L, Greeson J, Papadopoulos V. Beta-amyloid and oxidative stress jointly induce neuronal death, amyloid deposits, gliosis, and memory impairment in the rat brain. Pharmacology 2006; 76:19-33.

  • Linnstaedt SD, Kasprzak WK, Shapiro BA, Casey JL. The role of a metastable RNA secondary structure in hepatitis delta virus genotype III RNA editing. RNA. 2006; 12:1521-1533.

  • Mani A, Oh AS, Bowden ET, Lahusen T, Lorick KL, Weissman AM, Schlegel R, Wellstein A, Riegel AT. E6AP Mediates Regulated Proteasomal Degradation of the Nuclear Receptor Coactivator Amplified in Breast Cancer 1 in Immortalized Cells. Cancer Res. 2006; 66:8680-8686.

  • Nalbandian A, Djakiew D. The p75(NTR) metastasis suppressor inhibits urokinase plasminogen activator, matrix metalloproteinase-2 and matrix metalloproteinase-9 in PC-3 prostate cancer cells. Clin.Exp.Metastasis 2006; 23:107-116.

  • Papadopoulos V, Baraldi M, Guilarte TR, Knudsen TB, Lacapere JJ, Lindemann P, Norenberg MD, Nutt D, Weizman A, Zhang MR, Gavish M. Translocator protein (18kDa): new nomenclature for the peripheral-type benzodiazepine receptor based on its structure and molecular function. Trends Pharmacol.Sci. 2006; 27:402-409.

  • Papadopoulos V, Lecanu L, Brown RC, Han Z, Yao ZX. Peripheral-type benzodiazepine receptor in neurosteroid biosynthesis, neuropathology and neurological disorders. Neuroscience 2006; 138:749-756.

  • Pretner E, Amri H, Li W, Brown R, Lin CS, Makariou E, Defeudis FV, Drieu K, Papadopoulos V. Cancer-related overexpression of the peripheral-type benzodiazepine receptor and cytostatic anticancer effects of Ginkgo biloba extract (EGb 761). Anticancer Res. 2006; 26:9-22.

  • Rodriguez O, Fricke S, Chien C, Dettin L, Vanmeter J, Shapiro E, Dai HN, Casimiro M, Ileva L, Dagata J, Johnson MD, Lisanti MP, Koretsky A, Albanese C. Contrast-enhanced in vivo imaging of breast and prostate cancer cells by MRI. Cell Cycle 2006; 5:113-119.

  • Rodriguez-Ortner E, Hayes RB, Weissfeld J, Gelmann EP. Effect of homeodomain protein NKX3.1 R52C polymorphism on prostate gland size. Urology 2006; 67:311-315.

  • Saha T, Vardhini D, Tang Y, Katuri V, Jogunoori W, Volpe EA, Haines D, Sidawy A, Zhou X, Gallicano I, Schlegel R, Mishra B, Mishra L. RING finger-dependent ubiquitination by PRAJA is dependent on TGF-beta and potentially defines the functional status of the tumor suppressor ELF. Oncogene 2006; 25:693-705.

  • Shah S, Islam MN, Dakshanamurthy S, Rizvi I, Rao M, Herrell R, Zinser G, Valrance M, Aranda A, Moras D, Norman A, Welsh J, Byers SW. The molecular basis of vitamin D receptor and beta-catenin crossregulation. Mol.Cell 2006; 21:799-809.

  • Shand RL, Gelmann EP. Molecular biology of prostate-cancer pathogenesis. Curr.Opin.Urol. 2006; 16:123-131.

  • Tillement L, Lecanu L, Yao W, Greeson J, Papadopoulos V. The spirostenol (22R, 25R)-20alpha-spirost-5-en-3beta-yl hexanoate blocks mitochondrial uptake of Abeta in neuronal cells and prevents Abeta-induced impairment of mitochondrial function. Steroids 2006; 71:725-735.

  • Touny LH, Banerjee PP. Identification of both Myt-1 and Wee-1 as necessary mediators of the p21-independent inactivation of the cdc-2/cyclin B1 complex and growth inhibition of TRAMP cancer cells by genistein. Prostate 2006; 66:1542-1555.

  • Xie B, Tassi E, Swift MR, McDonnell K, Bowden ET, Wang S, Ueda Y, Tomita Y, Riegel AT, Wellstein A. Identification of the fibroblast growth factor (FGF)-interacting domain in a secreted FGF-binding protein by phage display. J.Biol.Chem. 2006; 281:1137-1144.

  • Xie Z, Yuan H, Yin Y, Zeng X, Bai R, Glazer RI. 3-phosphoinositide-dependent protein kinase-1 (PDK1) promotes invasion and activation of matrix metalloproteinases. BMC.Cancer 2006; 6:77.

  • Yin Y, Yuan H, Wang C, Pattabiraman N, Rao M, Pestell RG, Glazer RI. 3-phosphoinositide-dependent protein kinase-1 activates the peroxisome proliferator-activated receptor-gamma and promotes adipocyte differentiation. Mol.Endocrinol. 2006; 20:268-278.

Top

Earlier Publications
spacer